FDA Approved: ESCITALOPRAM — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approves Jubilant Cadista's supplemental application for escitalopram oxalate (generic escitalopram), expanding availability of a generic version.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM OXALATE)